SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Lone Star Bio
CNS Pharmaceuticals Announces Preliminary Results from Ongoing Potentially Pivotal Trial Evaluating Berubicin for the Treatment of Recurrent Glioblastoma Multiforme (GBM)
December 8, 2022
 · 
7 min read
Lone Star Bio
CNS Pharmaceuticals to Participate at the Virtual Investor “Ask the CEO” Event
December 5, 2022
 · 
1 min read
Lone Star Bio
CNS Pharmaceuticals Announces Reverse Stock Split
November 28, 2022
 · 
3 min read
Business
CNS Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals Announces Dosing of First Patient in Europe/France in Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
November 2, 2022
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals to Participate in The American Brain Tumor Association’s Breakthrough (ABTA) for Brain Tumors® 5K (BT5K) Run
October 10, 2022
 · 
2 min read
Biotech Beach
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Activation of First Clinical Trial Sites in Europe Evaluating Berubicin for the Treatment of GBM
October 7, 2022
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals Announces Activation of First Clinical Trial Sites in Europe for Ongoing Potentially Pivotal Global Trial Evaluating Berubicin for the Treatment of GBM
September 28, 2022
 · 
6 min read
Lone Star Bio
CNS Pharmaceuticals to Present at the Virtual Investor Innovations in Oncology - Ongoing Pivotal Global Study for Treatment of Glioblastoma Multiforme (GBM)
September 23, 2022
 · 
3 min read
Lone Star Bio
CNS Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 7, 2022
 · 
2 min read
Load More
JOBS